Embed Size (px)
Citation preview
What WSMOS is Doing for You
Represent the best interests of oncology practitioners and patients to all cancer care stakeholders in Washington State
Serve as the statewide representative of ASCO in Washington
Our Mission
Founded in 1993Currently: 15 Board Members representing
private practice, academic centers, hospital based clinics
2 Administrative staff 290 members
◦ 248 physicians◦ 42 affiliate members ARNP, PA, PharmD
The Important People
Risë Marie Cleland- WSMOS Executive Director
Liz Cleland- WSMOS Associate Director
Revised charter document
Revised board and task force structure
More sophisticated financial planning
Enhanced relations with corporate
sponsors
Membership drive
Expanded activities
Internal Restructuring 2011
Board MembersPresident Vincent J. Picozzi, MD, MMM
President ElectVicky E. Jones, MD
Secretary/TreasurerJonathan C. Britell, MD
Immediate Past PresidentJeffery C. Ward, MD
Sibel Blau, MD Thomas E. Boyd, MD James Congdon, DO John Fitzharris, MD Benjamin Greer, MD Jack Keech Jr., DO
Kenneth G. Kraemer, MD Matthew Lonergan, MD Richard A. McGee, MD,
FACP Thomas Tucker MD Robert Witham, MD
Board of Trustees
Task Force CommitteesEXECUTIVE
CHAIR: President, Vince Picozzi MEMBERS: President Elect, Vicky Jones and Immediate Past President, Jeffery Ward
TASKS: Lead the overall direction of the society, relationships with partner societies ASCO and ASH, function as nominating committee
FINANCE
CHAIR: Secretary/Treasurer, Jonathan BritellMEMBERS: President, Vince Picozzi as ex-officio and Robert Witham
TASKS: Assembling society budget, recommendations for revenue growth opportunities, guiding overall financial management.
MEETINGS & EDUCATION
CHAIR: Jack KeechMEMBERS: President, Vince Picozzi as ex-officio, Vicky Jones
TASKS: Leadership role in development of educational meetings
MEMBERSHIP
CO-CHAIRS: Vicky Jones and Jeffery WardMEMBERS: Sibel Blau, Richard McGee, Thomas Boyd, Matthew Lonergan, James Congdon, John Fitzharris, Kenneth Kraemer,
TASKS: To lead membership growth efforts
Task Force CommitteesPAYOR
CHAIR: Richard McGee
MEMBERS: Matthew Lonergan and Robert Witham
GOVERNMENT AFFAIRS
CHAIR: Jon Britell
MEMBERS: Robert Witham, Tom Boyd
PHARMACEUTICAL LIAISON
CHAIR: Sibel Blau MEMBERS: James Congdon and Kenneth Kraemer
PATIENT ADVOCACY
CHAIR: Vince PicozziMEMBERS: Mathew Lonergan, Thomas Tucker
Group Members Columbia Basin
Hematology Oncology
Harrison Medical Center
MultiCare Regional Cancer Center
North Star Lodge
Northwest Medical Specialties
Providence Regional Cancer Partnership
Providence Western Washington Oncology
Puget Sound Cancer Centers
Seattle Cancer Care Alliance
Swedish Cancer Institute
University of Washington
Virginia Mason Cancer Institute
Wenatchee Valley Medical Center
Diamond Members
Corporate Members
Gold Level AstraZeneca Bayer Onyx Bristol Meyers
Squibb Janssen Biotech Dendreon Eisai
Silver Level
Allos TherapeuticsGlaxoSmithKline
Genzyme
McKesson Merck Oncology Supply/ION Seattle Genetics Spectrum
Pharmaceuticals
Affiliation
Advocacy
Scholarship
Leadership
What We Do & Why You Want to Join
You can learn about…
◦ National oncology news◦ Statewide oncology news/legislative
updates◦ Billing and reimbursement updates◦ Practice resources and tools◦ WSMOS activities and events
◦ And,……. Much, much more coming!!!!!
WSMOS Affiliation
Payors (Noridian, private sector)
State Legislature
ASCO CAC
ASCO CPC/State Affiliate Program
ASH COP
WSMOS Advocacy
Spring and Fall Meetings ( Welcome, Drs. Swain and Swisher !!!!)
Seattle Blood Club Sponsorship
Host organization- Best of ASH (2008)
Host organization- Best of ASCO (2011)
WSMOS Scholarship
Individual
Societal◦ASCO Grants◦MAC jurisdiction meeting
WSMOS Leadership
$5,000 ASCO GRANT – APRIL 2006
OBJECTIVE:To explore the creation of a joint Washington-Alaska Medical Oncology Society.
OUTCOME:WSMOS provided guidance and support in the creation of an independent Alaska State Society which is now represented in the ASCO State Affiliate program.
$10,000 ASCO GRANT – APRIL 2007
OBJECTIVE:To develop a forum for ongoing regional collaboration between oncologists in AK, ID, OR and WA and the Jurisdiction 2 MAC
OUTCOME:A successful regional symposium and a plan for future regional symposiums and activities that will help the state societies of Alaska, Idaho, Oregon & Washington work as one with the MAC on shared issues of concern.
$10,000 ASCO GRANT – APRIL 2008
OBJECTIVE:To develop a comprehensive inventory of WA state oncology practices and their current use of midlevel providers and of their staffing profiles.
OUTCOME:The publication of an Analysis of Medical Personnel Educational and Employment Opportunities in Medical Oncology.
$5000 ASCO GRANT – APRIL 2010
OBJECTIVE:To create tools to be used to prepare providers for Medicare Recovery Audit Contractor (RAC) audits for both the inpatient and outpatient settings.
OUTCOME:A living document providing a prototype and tools for oncologists responding to RAC audits.
7:45-8:30am Breakfast with Exhibitors
8:30-9:15am Welcome & Introductions - What WSMOS Is Doing For You & Hazardous Drug Bill UpdateVince Picozzi, MD, MMM President, Jon Britell, MD Risë Cleland, WSMOS
9:15-10:15am ASCO & You Sandra Swain, MD ASCO, Jeffery Ward, MD, WSMOS
10:15-10:30amBreak with Exhibitors
10:30-11:45pm Best of San Antonio Breast Conference – HER 2 PathwaysSandra Swain, MD
11:45-12:45pm Lunch with Exhibitors
12:45-1:45pm Preparing for ICD-10 Michelle Lott, CPC & Bob Perna, WSMA
1:45pm-2:45pm Ovarian Translational ResearchLiz Swisher, MD
2:45-3:45pm Coping with Drug Shortages – Panel Discussion Jeff Ward, MD, Annie Lambert, PharmD, MultiCare Regional Cancer Center, Renee Curtis, PharmD, Everett Clinic
3:45- 4:30pm Medicare Refunds and Reporting Overpayments David Glaser, JD, Fredrickson and Byron
4:30-6:00pm Networking Cocktail ReceptionDiamond Member Recognition
AGENDA May 11, 2012 Cedarbrook Lodge, SeaTac
SAVE THE DATE! FALL CANCER CONFERENCE
NOVEMBER 16, 2012
CEDARBROOK LODGE
Your Washington State Medical Oncology Society
A Unified Community of Oncology Professionals
Promoting the Highest Professional Standards of Oncology Practice
NAVIGATING NIOSH
WSMOS AT WORK FOR YOU
Jonathan C. Britell MD May 11, 2012
Mandated that the Department of Labor and Industries adopt rules “consistent with but no more stringent than guidelines of National Institute for Occupational Safety and Health (NIOSH) regarding handling of chemotherapy hazardous drugs.”
First in the Nation
ESSB 5594 2011
◦ Stakeholder meetings: June 15, 2011◦ August 31, 2011
◦ Public Hearing on Rules: November 28, 2011 December 7, 2011
◦ Rules Published: January 3, 2012
◦ Advisory Committee: January 24, 2012 Meetings March 26, 2012
◦ May 7, 2012
PROCESS
Modifications from original proposed rules
Original Finalized
Original Proposed Rule
Scope: any exposure
Coverage: Physicians, PAs, ARNPs, RNs, LPNs, nurses aids Patient care assistive personnel, Pharmacists, Pharmacy techs, Environmental services, Shipping and handling
Actual Rule When exposure
reasonably anticipated based on type of drug
Coverage: Same except for nurses aids excluded
Modifications
Original Finalized
Hazardous Drug Control Program
In place July 1, 2012 Contents: Inventory and hazard assessment of
drugs, Policies and Procedures for Handling Engineering Controls Personal Protective Equipment Safe Handling Cleaning, housekeeping Spill Control MEDICAL SURVEILLANCE Personnel issues (pregnancy) Training Record Keeping
Hazardous Drug Control Program
Delayed ‘til Jan 1, 2014
Medical Surveillance deferred
Record keeping minimized
Modications
Original Finalized
Personal Protective Equipment
Double gloving during compounding, administering, or handling contaminated fluids, linens
Personal Protective Equipment
Double glove during compounding, and cleaning up large spills
Modifications
Original Finalized
Personal Protective Equipment
Change gloves every 30 minutes or when torn, punctured or contaminated
Gowns: polyethylene coated polypropylene
Personal Protective Equipment
Change gloves every 30 to 60 minutes or when torn, punctured or contaminated
Gowns: polyethylene coated polypropylene or other “non absorbent, non-linting material
Modifications
Original Finalized
Engineering Controls
Biologic safety cabinets
Containment isolators Closed system devices Safer Sharps devices Safety Interlocks
Engineering Controls
Closed system devices Safer Sharps devices Safety Interlocks Ventilated Cabinets
Modifications
Original Finalized
Medical Surveillance Anyone who handles
drugs or patient waste within 48 hours of administration
On hire, following exposure, regular schedule and at termination
Questionnaire, exam, lab, maintain records 10 years minimum
Medical Surveillance
All on hold until NIOSH can make sense of the science behind this and come up with reasonable rules
Modifications
Original Finalized
Record Keeping Training: Dates, Content, Name and title Medical Exposure Spill Records
Record Keeping
“Inform and train your employees about hazardous chemicals in your workplace.”
Modications
Original Finalized
Implementation
July 1, 2012
Implementation
Hazardous Drugs Control Program –
Jan 1, 2014 Employee Training July 1, 2014 Installation of
Ventilated Hoods Jan 1, 2015
L&I Advisory Board Role: To review a) new NIOSH recommendations b) new scientific/tech developments c) Unanticipated implementation issues d) Provide advisory recommendations to L&I
What’s Next?
L&I Advisory Board Make up:
5 Business Representatives
5 Labor Representatives
1 Non-voting Dept of Health Rep
What’s Next
L&I Advisory Board Representatives will be chosen from:
Outpatient Community Practices Community/Compounding Pharmacies Hospitals and Large Healthcare
Organizations Nursing Homes/Long term care Veterinary Practices State Agencies that are health care
employers
What’s Next
Practices/Hospitals/Pharmacies
Physical plant modificationDevelop Hazardous Drug Control Plan
L&I and all stakeholders: Develop Best Practices Repository Share Them We shouldn’t have to reinvent the wheel
What’s Next
Questions
Links: http://www.lni.wa.gov/Safety/Topics/AtoZ/HazardousDrugs/For latest updates on rules and further links to the rules themselves
